###begin article-title 0
A Role for NKG2D in NK Cell-Mediated Resistance to Poxvirus Disease
###end article-title 0
###begin p 1
###xml 0 16 <span type="species:ncbi:12643">Ectromelia virus</span>
###xml 18 22 <span type="species:ncbi:12643">ECTV</span>
###xml 62 70 <span type="species:ncbi:12643">mousepox</span>
###xml 76 82 <span type="species:ncbi:10090">murine</span>
###xml 97 102 <span type="species:ncbi:9606">human</span>
###xml 103 111 <span type="species:ncbi:10255">smallpox</span>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 158 166 <span type="species:ncbi:12643">mousepox</span>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
###xml 378 386 <span type="species:ncbi:12643">mousepox</span>
###xml 497 501 <span type="species:ncbi:10090">mice</span>
###xml 516 524 <span type="species:ncbi:12643">mousepox</span>
Ectromelia virus (ECTV) is an orthopoxvirus (OPV) that causes mousepox, the murine equivalent of human smallpox. C57BL/6 (B6) mice are naturally resistant to mousepox due to the concerted action of innate and adaptive immune responses. Previous studies have shown that natural killer (NK) cells are a component of innate immunity that is essential for the B6 mice resistance to mousepox. However, the mechanism of NK cell-mediated resistance to OPV disease remains undefined. Here we show that B6 mice resistance to mousepox requires the direct cytolytic function of NK cells, as well as their ability to boost the T cell response. Furthermore, we show that the activating receptor NKG2D is required for optimal NK cell-mediated resistance to disease and lethality. Together, our results have important implication towards the understanding of natural resistance to pathogenic viral infections.
###end p 1
###begin title 2
Author Summary
###end title 2
###begin title 3

###end title 3
###begin p 4
###xml 0 16 <span type="species:ncbi:12643">Ectromelia virus</span>
###xml 18 22 <span type="species:ncbi:12643">ECTV</span>
###xml 31 39 <span type="species:ncbi:12643">mousepox</span>
###xml 43 49 <span type="species:ncbi:10090">murine</span>
###xml 84 89 <span type="species:ncbi:9606">human</span>
###xml 90 98 <span type="species:ncbi:10255">smallpox</span>
###xml 100 104 <span type="species:ncbi:12643">ECTV</span>
###xml 216 224 <span type="species:ncbi:12643">mousepox</span>
###xml 246 250 <span type="species:ncbi:10090">mice</span>
###xml 252 256 <span type="species:ncbi:12643">ECTV</span>
###xml 323 331 <span type="species:ncbi:12643">mousepox</span>
###xml 444 448 <span type="species:ncbi:10090">mice</span>
###xml 504 508 <span type="species:ncbi:12643">ECTV</span>
###xml 530 538 <span type="species:ncbi:12643">mousepox</span>
###xml 779 787 <span type="species:ncbi:12643">mousepox</span>
###xml 1165 1169 <span type="species:ncbi:12643">ECTV</span>
Ectromelia virus (ECTV) causes mousepox, a murine disease that is the equivalent of human smallpox. ECTV normally penetrates through the periphery but rapidly spreads through the lymphatic system to vital organs. In mousepox-sensitive strains of mice, ECTV infection culminates with either rapid death or overt symptoms of mousepox due to very high loads that the virus reaches in vital organs, particularly the liver. However, some strains of mice such as C57BL/6 (B6) and 129 also become infected with ECTV but naturally resist mousepox by controlling the virus loads in vital organs and clearing the virus without clinical symptoms of disease. Natural killer (NK) cells are cells of the innate immune system previously shown to play an important role in natural resistance to mousepox. However, how NK cells protect from this disease is still unknown. In this paper we show that NK cells directly contribute to antiviral defenses by curbing virus dissemination to vital organs and also indirectly by augmenting the antiviral T cell response. We also demonstrate that optimal protection requires the activating NK cell receptor NKG2D which facilitates killing of ECTV-infected cells. Our work has important implications for the understanding of natural resistance to viral disease.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 257 258 257 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b001">1</xref>
###xml 369 370 369 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b002">2</xref>
###xml 371 372 371 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b003">3</xref>
###xml 559 560 559 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b004">4</xref>
###xml 0 16 <span type="species:ncbi:12643">Ectromelia virus</span>
###xml 18 22 <span type="species:ncbi:12643">ECTV</span>
###xml 48 56 <span type="species:ncbi:12643">mousepox</span>
###xml 114 119 <span type="species:ncbi:10090">mouse</span>
###xml 155 169 <span type="species:ncbi:10245">vaccinia virus</span>
###xml 171 175 <span type="species:ncbi:10245">VACV</span>
###xml 182 187 <span type="species:ncbi:9606">human</span>
###xml 197 210 <span type="species:ncbi:10255">variola virus</span>
###xml 225 233 <span type="species:ncbi:10255">smallpox</span>
###xml 240 255 <span type="species:ncbi:10244">monkeypox virus</span>
###xml 288 294 <span type="species:ncbi:9606">people</span>
###xml 380 388 <span type="species:ncbi:10255">smallpox</span>
###xml 390 398 <span type="species:ncbi:12643">mousepox</span>
###xml 462 470 <span type="species:ncbi:12643">mousepox</span>
###xml 511 519 <span type="species:ncbi:10255">smallpox</span>
Ectromelia virus (ECTV), the causative agent of mousepox, is an orthopoxvirus (OPV) with host specificity for the mouse. It is genetically very similar to vaccinia virus (VACV), the human pathogen variola virus (the agent of smallpox), and monkeypox virus [1], which sporadically infects people in Africa and produced a recent outbreak in the midwestern United States [2,3]. Like smallpox, mousepox is a severe disease with high mortality and infectivity. Thus, mousepox constitutes an excellent model to study smallpox and exanthematous diseases in general [4].
###end p 6
###begin p 7
###xml 369 370 369 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b005">5</xref>
###xml 579 580 579 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b006">6</xref>
###xml 581 582 581 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b008">8</xref>
###xml 13 18 <span type="species:ncbi:10090">mouse</span>
###xml 48 52 <span type="species:ncbi:12643">ECTV</span>
###xml 185 193 <span type="species:ncbi:12643">mousepox</span>
###xml 394 398 <span type="species:ncbi:10090">mice</span>
###xml 402 410 <span type="species:ncbi:12643">mousepox</span>
Although all mouse strains can be infected with ECTV, the outcome of the infection following footpad inoculation varies. Some sensitive strains, such as DBA/2, A/J, and BALB/c, develop mousepox and suffer high mortality during the first 2 wk post-infection, whereas other strains, such as C57BL/6 (B6), clear the infection without visible symptoms of systemic disease [5]. The resistance of B6 mice to mousepox is not due to an inherent decreased ability of the virus to replicate in this strain, but is a result of the combined action of the innate and adaptive immune systems [6-8].
###end p 7
###begin p 8
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b009">9</xref>
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b010">10</xref>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b011">11</xref>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b013">13</xref>
###xml 465 467 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b014">14</xref>
###xml 563 565 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b015">15</xref>
###xml 566 568 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b017">17</xref>
###xml 271 292 <span type="species:ncbi:10359">human cytomegalovirus</span>
###xml 350 354 <span type="species:ncbi:10090">mice</span>
###xml 388 393 <span type="species:ncbi:10090">mouse</span>
###xml 411 415 <span type="species:ncbi:10366?0.7619047619047619">MCMV</span>
###xml 545 549 <span type="species:ncbi:10090">mice</span>
###xml 553 561 <span type="species:ncbi:12643">mousepox</span>
Natural killer (NK) cells are innate effector cells serving as a first line of defense against certain viral infections and tumors [9,10]. For example, NK cell-deficient individuals become sick or succumb to normally non-life-threatening infections with the herpes virus human cytomegalovirus (HCMV) or varicella zoster [11-13]. In addition, C57BL/6 mice, which are normally resistant to mouse cytomegalovirus (MCMV), become susceptible when NK cells are depleted [14]. Similarly, NK cells have been shown to be crucial for the resistance of B6 mice to mousepox [15-17].
###end p 8
###begin p 9
###xml 115 117 115 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b018">18</xref>
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b019">19</xref>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b019">19</xref>
###xml 465 469 465 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rmp1</italic>
###xml 671 673 671 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b016">16</xref>
###xml 674 676 674 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b018">18</xref>
###xml 928 932 928 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cmv1</italic>
###xml 1184 1186 1184 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b020">20</xref>
###xml 1187 1189 1187 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b023">23</xref>
###xml 1367 1371 1367 1371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rmp1</italic>
###xml 1423 1425 1423 1425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b024">24</xref>
###xml 519 523 <span type="species:ncbi:10090">mice</span>
###xml 534 542 <span type="species:ncbi:12643">mousepox</span>
###xml 770 774 <span type="species:ncbi:10090">mice</span>
###xml 845 849 <span type="species:ncbi:10090">mice</span>
###xml 978 982 <span type="species:ncbi:10090">mice</span>
###xml 986 990 <span type="species:ncbi:10366?0.7619047619047619">MCMV</span>
###xml 1105 1109 <span type="species:ncbi:10366?0.7619047619047619">MCMV</span>
###xml 1300 1308 <span type="species:ncbi:12643">mousepox</span>
The activation of NK cells is regulated by a balance of signals transduced by activating and inhibitory receptors [18,19]. It is thought that continuous signaling through inhibitory receptors maintain NK cells in a resting state, and the loss of inhibitory signals (i.e., due to downregulation of MHC class I on target cells) or the expression of ligands for activating receptors on target cells results in NK cell activation [19]. Previous studies have shown that Rmp1, a dominant gene important for the ability of B6 mice to resist mousepox, maps to the "NK complex," a region of chromosome 6 that encodes a large number of NK cell-activating and inhibitory receptors [16,18]. Well-defined activating receptors encoded by polymorphic genes within the NK complex in B6 mice include NKR-P1C (NK1.1, the prototypic marker defining NK cells in B6 mice), the Ly49 family members Ly49H and Ly49D, NKG2D, CD94-NKG2C, and CD94-NKG2E. Cmv1, a gene responsible for the resistance of B6 mice to MCMV infection and also mapped to the NK complex, has been shown to be the activating receptor Ly49H that binds to the MCMV-encoded MHC-like protein m157 expressed on the surface of infected cells [20-23]. On the other hand, the positive identification of any activating NK cell receptor involved in resistance to mousepox is still lacking, even though it has been speculated that Rmp1 might be the prototypic activating receptor NK1.1 [24].
###end p 9
###begin p 10
###xml 298 306 <span type="species:ncbi:12643">mousepox</span>
In this study, we show that NK cells directly contribute to antiviral defenses by curbing virus dissemination to central organs and also indirectly by augmenting the antiviral T cell response. We also demonstrate that the activating receptor NKG2D is involved in the NK cell-mediated resistance to mousepox, whereas NK1.1 is not.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
###xml 14 22 <span type="species:ncbi:12643">Mousepox</span>
Resistance to Mousepox Requires NK Cells, but Only during the First 4 d Post-Infection
###end title 12
###begin p 13
###xml 45 46 45 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b005">5</xref>
###xml 52 59 52 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0040030-t001">Table 1</xref>
###xml 569 576 569 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0040030-t001">Table 1</xref>
###xml 1618 1626 1618 1626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0040030-g001">Figure 1</xref>
###xml 1689 1690 1689 1690 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1763 1771 1763 1771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0040030-g001">Figure 1</xref>
###xml 3 7 <span type="species:ncbi:10090">mice</span>
###xml 34 42 <span type="species:ncbi:12643">mousepox</span>
###xml 132 140 <span type="species:ncbi:12643">mousepox</span>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
###xml 203 207 <span type="species:ncbi:12643">ECTV</span>
###xml 669 673 <span type="species:ncbi:12643">ECTV</span>
###xml 727 731 <span type="species:ncbi:10090">mice</span>
###xml 740 746 <span type="species:ncbi:9986">rabbit</span>
###xml 776 781 <span type="species:ncbi:10090">mouse</span>
###xml 871 879 <span type="species:ncbi:12643">mousepox</span>
###xml 900 904 <span type="species:ncbi:10090">mice</span>
###xml 1157 1161 <span type="species:ncbi:10090">mice</span>
###xml 1205 1209 <span type="species:ncbi:12643">ECTV</span>
###xml 1268 1272 <span type="species:ncbi:10090">mice</span>
###xml 1350 1354 <span type="species:ncbi:10090">mice</span>
###xml 1453 1457 <span type="species:ncbi:10090">mice</span>
###xml 1612 1616 <span type="species:ncbi:10090">mice</span>
###xml 1668 1672 <span type="species:ncbi:10090">mice</span>
###xml 1757 1761 <span type="species:ncbi:10090">mice</span>
###xml 1969 1977 <span type="species:ncbi:12643">mousepox</span>
B6 mice are normally resistant to mousepox ([5] and Table 1). To determine whether and when NK cells are required for resistance to mousepox, we depleted NK cells in B6 mice at different times following ECTV infection with either anti-asialo GM1 antiserum or anti-NK1.1 mAb PK136. Anti-asialo GM1 antiserum depletes NK cells and some activated T cells but not NKT cells, whereas PK136 depletes NK cells and NKT cells but not T cells. Thus, the use of both Abs allowed us to better distinguish the role of NK cells from that of other lymphocyte populations. As shown in Table 1, depletion of NK cells with either Ab on or before day 4 post-infection (PI) with 3,000 pfu ECTV resulted in very high mortality, while mock-depleted mice (normal rabbit sera for anti-asialo GM1 and mouse IgG2a for PK136) were still resistant (data not shown). On the other hand, resistance to mousepox was maintained when mice were depleted of NK cells on day 6 PI, indicating an important role for the physical presence of NK cells at the early, but not later, stages of infection. In additional experiments, we found that five out of five and two out of five PK136-depleted B6 mice succumbed when infected with 100 and 1 pfu ECTV, respectively. Identical results were obtained for BALB/c mice infected with the same virus stock. This shows that the susceptibility of B6 mice depleted of NK cells on the day of infection is similar to that of genetically susceptible BALB/c mice. In agreement with the increased mortality, NK cell depletion resulted in severe necrosis and splenic lymphopenia as compared to non-depleted (intact) B6 mice (Figure 1A). Furthermore, 7 d PI, NK cell-depleted mice had more than 103-fold higher viral titers in both the spleen and liver than intact mice (Figure 1B), indicating a more severe systemic infection in the absence of NK cells. Thus, NK cells are required in the early phase of infection to control viral loads in central organs and to resist lethal mousepox.
###end p 13
###begin p 14
###xml 40 48 <span type="species:ncbi:12643">Mousepox</span>
###xml 62 66 <span type="species:ncbi:12643">ECTV</span>
NK Cells Are Required for Resistance to Mousepox during Early ECTV Infection
###end p 14
###begin title 15
###xml 79 83 <span type="species:ncbi:12643">ECTV</span>
The Rapid Kinetics of the NK Cell Response Controls the Early Dissemination of ECTV to Central Organs by Using IFN-gamma- and Perforin-Dependent Mechanisms
###end title 15
###begin p 16
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 100 104 <span type="species:ncbi:12643">ECTV</span>
###xml 280 284 <span type="species:ncbi:10090">mice</span>
Intact or NK cell-depleted (treated with anti-NK1.1 mAb PK136) B6 mice were infected with 3,000 pfu ECTV. (A) 7 d PI, the absolute numbers of live lymphocytes in the spleen were determined by trypan blue exclusion. Data correspond to the average +/- SD of pooled spleens of three mice from five independent experiments.
###end p 16
###begin p 17
###xml 134 138 <span type="species:ncbi:10090">mice</span>
(B) 7 d PI, virus titers in spleen and liver were determined by plaque assay. Data correspond to the average +/- SD of six individual mice from two independent experiments.
###end p 17
###begin p 18
###xml 7 11 <span type="species:ncbi:10090">mice</span>
###xml 31 35 <span type="species:ncbi:12643">ECTV</span>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
(C) B6 mice were infected with ECTV in the footpad. The NK cell response, as determined by the percentage of NK cells expressing intracellular IFN-gamma, at the indicated times PI was determined in the indicated organs. Data correspond to pools of three mice and are representative of three similar experiments.
###end p 18
###begin p 19
###xml 190 191 190 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 203 204 197 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 273 274 263 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 285 286 269 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 84 88 <span type="species:ncbi:12643">ECTV</span>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
###xml 348 352 <span type="species:ncbi:10090">mice</span>
(D) Representative flow cytometric analysis of D-LN from mice infected for 2 d with ECTV and from control uninfected mice. Upper panel: Dot plots indicating the proportion of NK cells (NK1.1+, CD3epsilon-). Lower panel: GzB and IFN-gamma production by gated NK cells (NK1.1+/CD3epsilon- gate of the upper panels). Data correspond to pools of three mice and are representative of at least five experiments. >98% of cells stained with control Ig were in the lower left quadrant of the dot plots (not shown).
###end p 19
###begin p 20
###xml 55 56 55 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 68 69 62 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
###xml 31 35 <span type="species:ncbi:12643">ECTV</span>
(E) B6 mice were infected with ECTV, and NK cell (NK1.1+, CD3epsilon-) proliferation was determined at different times PI in the indicated organs by using a 3-h BrdU incorporation assay. Data are representative of three independent experiments.
###end p 20
###begin p 21
###xml 156 157 156 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 169 170 163 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 69 73 <span type="species:ncbi:12643">ECTV</span>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
(F) Flow cytometric analysis of D-LN from mice infected for 2 d with ECTV and from control uninfected mice. Upper panels: Plots are gated on NK cells (NK1.1+, CD3epsilon-). Lower panels: Gated on R1, R2, and R3 populations from the upper-right (infected) plot. Data are representative of three independent experiments.
###end p 21
###begin p 22
###xml 14 18 <span type="species:ncbi:10090">mice</span>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
###xml 145 149 <span type="species:ncbi:12643">ECTV</span>
###xml 262 266 <span type="species:ncbi:10090">mice</span>
(G) Intact B6 mice and B6 mice depleted of NK cells (treated with anti-NK1.1) or T cells (treated with anti-CD4 and anti-CD8) were infected with ECTV and virus titers in spleen and liver were determined on day 3 PI. Data are the average +/- SD of six individual mice from two experiments.
###end p 22
###begin p 23
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 65 69 <span type="species:ncbi:12643">ECTV</span>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
(H) Wild-type and IFN-gamma-deficient B6 mice were infected with ECTV in the footpad, and virus titers were determined 3 d PI. Data are the average +/- SD of three individual mice and is representative of two individual experiments.
###end p 23
###begin p 24
###xml 34 38 <span type="species:ncbi:10090">mice</span>
###xml 58 62 <span type="species:ncbi:12643">ECTV</span>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
(I) Wild-type and Pf-deficient B6 mice were infected with ECTV in the footpad and virus titers were determined 3 d PI. Data are the average +/- SD of three individual mice and are representative of two individual experiments.
###end p 24
###begin title 25
Early Recruitment of NK Cells to the Draining Lymph Nodes
###end title 25
###begin p 26
###xml 305 313 285 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0040030-g001">Figure 1</xref>
###xml 319 320 299 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0040030-g001">1</xref>
###xml 376 378 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b025">25</xref>
###xml 472 480 452 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0040030-g001">Figure 1</xref>
###xml 571 579 551 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0040030-g001">Figure 1</xref>
###xml 767 771 <span type="species:ncbi:10090">mice</span>
We next evaluated the NK cell response at different times PI by flow cytometry. NK cell production of IFN-gamma and granzyme B (GzB) in the draining lymph nodes (D-LN) was already induced 24 h PI, reaching the peak at 48 h PI when approximately20% of the NK cells produced IFN-gamma and 43% produced GzB (Figure 1C and 1D), a time when T cell responses were not yet detected [25]. This was accompanied by a 2- to 4-fold increase in the proportion of NK cells in the D-LN (Figure 1D). NK cell responses in non-draining LN and spleen, however, did not peak until day 5 PI (Figure 1C). In addition, histopathological analysis of the infected footpads on day 2 PI did not show leukocyte infiltration or other signs of inflammation in either intact or NK cell-depleted B6 mice (data not shown). Thus, at very early stages of infection the NK cell response is restricted to the D-LN.
###end p 26
###begin p 27
###xml 517 525 517 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0040030-g001">Figure 1</xref>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
###xml 194 198 <span type="species:ncbi:10090">mice</span>
To distinguish whether the increase in NK cell number in D-LN resulted from recruitment and/or proliferation, we inoculated mice at different stages of infection with BrdU IP and sacrificed the mice 3 h later to determine BrdU incorporation by flow cytometric analysis. Very few NK cells incorporated BrdU in the D-LN during the first 3 d PI, suggesting increased migration to the D-LN at early times PI. In fact, on day 3 and 5 PI, the BrdU incorporation in NK cells in spleen and liver was higher than in the D-LN (Figure 1E). Thus, the increase of NK cells in the D-LN on day 2 PI is mostly due to recruitment rather than proliferation.
###end p 27
###begin p 28
###xml 68 69 68 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 192 193 192 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 200 201 200 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 212 213 212 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 220 221 220 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 236 237 236 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 244 245 244 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b026">26</xref>
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b027">27</xref>
###xml 721 729 721 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0040030-g001">Figure 1</xref>
###xml 796 797 792 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 808 809 804 805 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 855 863 851 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0040030-g001">Figure 1</xref>
###xml 562 566 <span type="species:ncbi:12643">ECTV</span>
###xml 1075 1079 <span type="species:ncbi:12643">ECTV</span>
A recent report by Hayakawa and Smyth revealed that peripheral NK1.1+ NK cells can be divided into three subsets according to their expression of CD11b and CD27, which they designated R1 (CD27+, CD11b-), R2 (CD27+, CD11b+), and R3 (CD27-, CD11b+), that represent NK cells at distinct developmental stages [26,27]. R1 cells are immature, whereas R2 and R3 fractionate the mature cells into two populations. While adoptively transferred R2 cells can differentiate into R3 cells, R3 cells appear to be terminally differentiated. We, therefore, investigated whether ECTV infection altered the maturation phenotype of NK cells in the D-LN and found a substantial increase in NK cells with a mature (R3) phenotype on day 2 PI (Figure 1F, upper panels). Of interest, the majority of effectors (IFN-gamma+ and/or GzB+) were within this mature NK cell population (Figure 1F, lower panels). Together, these data demonstrate that the increased NK cell number in the D-LN at early time points PI is mainly a result of recruitment. Moreover, the data show that the NK cells responding to ECTV infection are mature or mature very rapidly after infection.
###end p 28
###begin title 29
Control of Early Virus Dissemination by NK Cells Is Dependent on IFN-gamma and Perforin
###end title 29
###begin p 30
###xml 366 367 366 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 375 376 375 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 491 492 491 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 722 723 722 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 896 897 896 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 907 915 907 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0040030-g001">Figure 1</xref>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
###xml 597 601 <span type="species:ncbi:10090">mice</span>
###xml 682 686 <span type="species:ncbi:10090">mice</span>
###xml 860 864 <span type="species:ncbi:10090">mice</span>
###xml 890 894 <span type="species:ncbi:10090">mice</span>
###xml 1013 1017 <span type="species:ncbi:12643">ECTV</span>
We hypothesized that the observed early recruitment to and activation of NK cells in the D-LN may contribute to the prevention of virus dissemination to central organs. Thus, we depleted NK cells in B6 mice with anti-NK1.1 mAb (PK136) and determined viral titers in spleen and liver on day 3 PI. To rule out a role for T cells at this stage we also depleted both CD4+ and CD8+ T cells by using a combination of anti-CD4 (GK1.5) and anti-CD8 (2.43) mAbs. Depletion of NK cells resulted in >103-fold increase in viral loads in the spleen, while a much lower increase in virus titers was observed in mice depleted of T cells. The slight increase in virus titers in the T cell-depleted mice was not statistically significant (p = 0.09) and was not reproducible. We also observed a significant increase in virus titers on day 3 PI in the livers of NK cell-depleted mice, but not T cell-depleted mice (p = 0.07) (Figure 1G). Therefore, NK cells, and not T cells, are responsible for limiting the early dissemination of ECTV from the site of infection to central organs.
###end p 30
###begin p 31
###xml 147 149 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b028">28</xref>
###xml 248 250 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b029">29</xref>
###xml 251 253 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b030">30</xref>
###xml 555 563 535 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0040030-g001">Figure 1</xref>
###xml 589 597 569 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0040030-g001">Figure 1</xref>
###xml 178 182 <span type="species:ncbi:10090">mice</span>
###xml 238 246 <span type="species:ncbi:12643">mousepox</span>
###xml 519 523 <span type="species:ncbi:10090">mice</span>
###xml 583 587 <span type="species:ncbi:10090">mice</span>
###xml 658 662 <span type="species:ncbi:10090">mice</span>
NK cells can control viral infections by producing antiviral cytokines, such as IFN-gamma, or by perforin (Pf)-mediated killing of infected cells [28]. Others have shown that B6 mice deficient in either Pf or IFN-gamma are susceptible to mousepox [29,30]. However, whether the early control of virus dissemination (day 3 PI) by NK cells requires IFN-gamma and/or Pf-mediated killing is unknown. We, therefore, compared virus titers on day 3 PI in the spleens of wild-type (WT), IFN-gamma-deficient, and Pf-deficient B6 mice. We found that both IFN-gamma-(Figure 1H) and Pf-deficient mice (Figure 1I) had significantly elevated virus titers as compared to B6 mice. Thus, the early control of virus dissemination by NK cells requires both the antiviral effects of IFN-gamma and Pf-mediated cytotoxicity.
###end p 31
###begin title 32
Reduced T Cell Response in the Absence of NK Cells
###end title 32
###begin p 33
###xml 67 68 67 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 125 126 125 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b008">8</xref>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b025">25</xref>
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b031">31</xref>
###xml 429 437 429 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0040030-g001">Figure 1</xref>
###xml 442 449 442 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0040030-t001">Table 1</xref>
###xml 514 521 514 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0040030-t001">Table 1</xref>
###xml 580 582 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b025">25</xref>
###xml 908 909 908 909 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 917 918 917 918 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1012 1013 1000 1001 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1036 1037 1024 1025 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1080 1088 1068 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0040030-g002">Figure 2</xref>
###xml 1322 1323 1310 1311 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1497 1498 1469 1470 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1545 1546 1517 1518 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1594 1602 1562 1570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0040030-g002">Figure 2</xref>
###xml 1664 1665 1632 1633 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1736 1737 1692 1693 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1783 1784 1727 1728 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1900 1908 1840 1848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0040030-g001">Figure 1</xref>
###xml 1984 1985 1924 1925 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 115 123 <span type="species:ncbi:12643">mousepox</span>
###xml 208 216 <span type="species:ncbi:12643">mousepox</span>
###xml 690 694 <span type="species:ncbi:12643">ECTV</span>
###xml 769 773 <span type="species:ncbi:10090">mice</span>
###xml 778 782 <span type="species:ncbi:10090">mice</span>
###xml 977 981 <span type="species:ncbi:10090">mice</span>
###xml 1074 1078 <span type="species:ncbi:10090">mice</span>
###xml 1092 1096 <span type="species:ncbi:10090">Mice</span>
###xml 1588 1592 <span type="species:ncbi:10090">mice</span>
###xml 1618 1622 <span type="species:ncbi:10090">mice</span>
###xml 1861 1865 <span type="species:ncbi:10090">mice</span>
###xml 2027 2031 <span type="species:ncbi:10090">mice</span>
Our previous studies and those of others showed that an optimal CD8+ T cell response is required for resistance to mousepox [8,25,31]. The data above indicate that NK cells have a direct effect in preventing mousepox by curbing virus dissemination during early infection. However, NK depletion at early stages resulted in an increase in spleen and liver viral titers, splenic lymphopenia, liver pathology, and death on day 7 PI (Figure 1 and Table 1), a time when the presence of NK cells was no longer necessary (Table 1) and when the T cell response should have already peaked [25]. This suggested that the absence of NK cells may have an impact on the establishment of the adaptive anti-ECTV T cell response. Thus, we compared in vivo T cell proliferation in intact mice and mice depleted of NK cells on day 0 PI. We found that on day 5 PI (when the T cell response normally peaks in D-LN), only a few CD8+ and CD4+ T cells incorporated BrdU in the D-LN of NK cell-depleted mice, while approximately40% of CD8+ T cells and 20% of CD4+ T cells incorporated BrdU in intact mice (Figure 2A). Mice depleted of NK cells on day 0 PI also had substantially reduced T cell proliferation in spleen and liver on day 7 PI (the time when the T cell response normally peaks in the spleen, data not shown). We also determined the CD8+ T cell response by intracellular staining for the effector molecules, GzB and IFN-gamma. On 7 d PI, there was a strong T cell response in spleen with approximately70% of CD8+ T cells producing GzB and more than 10% of CD8+ T cells producing IFN-gamma in intact B6 mice (Figure 2B). However, in mice depleted of NK cells on day 0 PI, the CD8+ T cell response was greatly reduced, with only approximately30% of CD8+ T cells producing GzB and approximately5% CD8+ T cells producing IFN-gamma. Furthermore, because infected NK cell-depleted mice had severely lymphopenic spleens (Figure 1A), they also had a 16-fold reduction in the absolute number of effector CD8+ T cells as compared with infected intact mice (data not shown). These results indicate that the adaptive T cell response was substantially reduced in the absence of NK cells.
###end p 33
###begin title 34
Reduced T Cell Responses in the Absence of NK Cells
###end title 34
###begin p 35
###xml 200 201 200 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 236 237 236 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
###xml 68 72 <span type="species:ncbi:12643">ECTV</span>
(A) Intact or NK cell-depleted B6 mice were infected with 3,000 pfu ECTV. T cell proliferation on day 5 PI was determined in the D-LN by using a 3-h BrdU incorporation assay. Upper panel: gated on CD8+ T cells; lower panel: gated on CD4+ T cells.
###end p 35
###begin p 36
###xml 102 103 98 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 172 173 168 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
###xml 58 62 <span type="species:ncbi:12643">ECTV</span>
(B) Intact or NK cell-depleted B6 mice were infected with ECTV. Production of IFN-gamma and GzB by CD8+ T cells in spleen on day 7 PI was determined. Plots are gated on CD8+ T cells. Data are representative of three independent experiments.
###end p 36
###begin title 37
###xml 14 22 <span type="species:ncbi:12643">Mousepox</span>
Resistance to Mousepox Involves the Activating Receptor NKG2D but Not NK1.1
###end title 37
###begin p 38
###xml 435 439 435 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rmp1</italic>
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b024">24</xref>
###xml 580 582 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b020">20</xref>
###xml 583 585 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b022">22</xref>
###xml 825 827 825 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b022">22</xref>
###xml 1040 1047 1040 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0040030-t002">Table 2</xref>
###xml 76 80 <span type="species:ncbi:12643">ECTV</span>
###xml 185 193 <span type="species:ncbi:12643">mousepox</span>
###xml 335 343 <span type="species:ncbi:12643">mousepox</span>
###xml 373 377 <span type="species:ncbi:10090">mice</span>
###xml 574 578 <span type="species:ncbi:10366?0.7619047619047619">MCMV</span>
###xml 663 667 <span type="species:ncbi:10090">mice</span>
###xml 680 684 <span type="species:ncbi:10090">mice</span>
###xml 774 778 <span type="species:ncbi:10090">mice</span>
###xml 844 848 <span type="species:ncbi:10090">mice</span>
###xml 858 862 <span type="species:ncbi:10090">mice</span>
###xml 891 899 <span type="species:ncbi:12643">mousepox</span>
###xml 1012 1016 <span type="species:ncbi:10090">mice</span>
###xml 1112 1116 <span type="species:ncbi:10090">mice</span>
###xml 1131 1139 <span type="species:ncbi:12643">mousepox</span>
To gain insight into the mechanism whereby NK cells become activated during ECTV infection, we explored whether various known NK cell-activating receptors are involved in resistance to mousepox. We first focused on NK1.1 and on the activating receptors of the Ly49 family. We focused on these receptors because NK1.1 is not encoded in mousepox-susceptible DBA/2 and BALB/c mice. Furthermore, it has been speculated that NK1.1 might be Rmp1 [24]. In addition, there is good precedent for the involvement of Ly49H in NK cell-mediated antiviral responses, more specifically to MCMV [20-22]. Ly49D and Ly49H are the only activating receptors of the Ly49 family in B6 mice. Because B6 mice selectively deficient in NK1.1, Ly49H, or Ly49D are not available, we first used 129/Sve mice, which do not express any of these receptors [22]. Similar to B6 mice, 129/Sve mice were naturally resistant to mousepox but became sensitive when depleted of NK cells with anti-asialo GM1 Ab (PK136 could not be used because 129/Sve mice do not express NK1.1) (Table 2). This demonstrates that NK cells are also required for 129/Sve mice resistance to mousepox but that NK1.1, Ly49D, or Ly49H are not essential for resistance because 129/Sve do not possess these receptors.
###end p 38
###begin p 39
###xml 52 60 <span type="species:ncbi:12643">Mousepox</span>
NKG2D Is Involved in NK Cell-Mediated Resistance to Mousepox
###end p 39
###begin p 40
###xml 512 514 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b032">32</xref>
###xml 651 653 631 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b033">33</xref>
###xml 740 747 710 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0040030-t002">Table 2</xref>
###xml 911 912 881 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b008">8</xref>
###xml 913 915 883 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b031">31</xref>
###xml 997 999 957 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b032">32</xref>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
###xml 138 146 <span type="species:ncbi:12643">mousepox</span>
###xml 311 315 <span type="species:ncbi:10090">mice</span>
###xml 506 510 <span type="species:ncbi:10090">mice</span>
###xml 686 690 <span type="species:ncbi:10090">mice</span>
###xml 730 738 <span type="species:ncbi:12643">mousepox</span>
###xml 817 821 <span type="species:ncbi:10090">mice</span>
###xml 825 833 <span type="species:ncbi:12643">mousepox</span>
###xml 901 909 <span type="species:ncbi:12643">mousepox</span>
###xml 1086 1094 <span type="species:ncbi:12643">mousepox</span>
The results above suggested, but did not formally prove that Ly49H, Ly49D, and/or NK1.1 are not required for the resistance of B6 mice to mousepox, because it remained possible that Ly49H, Ly49D, and/or NK1.1 play a role in B6 resistance but that other activating receptors substitute their function in 129/Sve mice. Although it is not possible to definitively rule out the participation Ly49H or Ly49D in B6 resistance with currently available reagents, we took advantage of FcepsilonRIgamma-deficient B6 mice [32] to rule out a role for NK1.1. It is known that NK1.1 signaling requires association with the ITAM-containing FcepsilonRIgamma adapter [33]. FcepsilonRIgamma-deficient B6 mice, however, were completely resistant to mousepox (Table 2), demonstrating that NK1.1 is not essential for the resistance of B6 mice to mousepox. In addition, because Abs are required for long-term resistance to mousepox [8,31] and FcepsilonRIgamma is required for Ab-dependent cellular cytotoxicity (ADCC) [32], these data also demonstrate that ADCC is not involved in Ab-dependent resistance to mousepox.
###end p 40
###begin p 41
###xml 166 167 158 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 193 194 185 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 377 379 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b034">34</xref>
###xml 620 622 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b035">35</xref>
###xml 623 625 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b037">37</xref>
###xml 717 724 709 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0040030-t002">Table 2</xref>
###xml 72 80 <span type="species:ncbi:12643">mousepox</span>
###xml 318 326 <span type="species:ncbi:12643">mousepox</span>
###xml 354 358 <span type="species:ncbi:10090">mice</span>
###xml 370 374 <span type="species:ncbi:10090">mice</span>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
###xml 645 649 <span type="species:ncbi:10090">mice</span>
###xml 674 677 <span type="species:ncbi:10116">rat</span>
###xml 838 846 <span type="species:ncbi:12643">mousepox</span>
We addressed whether the activating receptor NKG2D might be involved in mousepox resistance. NKG2D is expressed by NK cells and some T cells, including gammadelta-TcR+ T cells and activated CD8+ T cells. Although not polymorphic, this activating receptor is expressed at somewhat lower levels on activated NK cells of mousepox-susceptible NOD and BALB/c mice than in B6 mice ([34] and unpublished data). Because NKG2D-deficient mice are not available, we took advantage of the anti-NKG2D mAb CX5 that, in vivo, blocks binding of NKG2D to its ligands and causes its internalization without depleting NKG2D-bearing cells [35-37]. We inoculated B6 mice with CX5 mAb or control rat IgG 1 d before and 2 d PI. As shown in Table 2, CX5 treatment resulted in 50% mortality suggesting that NKG2D is involved in the NK cell-mediated resistance to mousepox.
###end p 41
###begin p 42
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b038">38</xref>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b040">40</xref>
###xml 470 477 470 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0040030-t002">Table 2</xref>
###xml 3 7 <span type="species:ncbi:10090">mice</span>
###xml 146 154 <span type="species:ncbi:12643">mousepox</span>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 219 227 <span type="species:ncbi:12643">mousepox</span>
###xml 297 301 <span type="species:ncbi:10090">mice</span>
###xml 363 367 <span type="species:ncbi:12643">ECTV</span>
###xml 407 411 <span type="species:ncbi:10090">mice</span>
###xml 460 468 <span type="species:ncbi:12643">mousepox</span>
In mice, NKG2D signals through either DAP10 or DAP12 adapter proteins, whereas Ly49H and D signal through DAP12 [38-40]; therefore, we determined mousepox susceptibility in either DAP12- or DAP10-deficient mice on a B6 mousepox-resistant background. We found that more than 50% of DAP12-deficient mice developed the typical skin rash, but only 10% died following ECTV infection, whereas all DAP10-deficient mice survived without showing ostensible symptoms of mousepox (Table 2).
###end p 42
###begin p 43
###xml 377 385 377 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0040030-g003">Figure 3</xref>
###xml 457 458 457 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 605 606 605 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 643 651 643 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0040030-g003">Figure 3</xref>
###xml 1459 1461 1459 1461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b041">41</xref>
###xml 81 89 <span type="species:ncbi:12643">mousepox</span>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
###xml 438 442 <span type="species:ncbi:10090">mice</span>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
###xml 775 783 <span type="species:ncbi:12643">mousepox</span>
###xml 902 910 <span type="species:ncbi:12643">mousepox</span>
###xml 1216 1224 <span type="species:ncbi:12643">mousepox</span>
###xml 1249 1253 <span type="species:ncbi:10090">mice</span>
###xml 1286 1294 <span type="species:ncbi:12643">mousepox</span>
###xml 1375 1379 <span type="species:ncbi:10090">mice</span>
###xml 1388 1392 <span type="species:ncbi:10366?0.7619047619047619">MCMV</span>
###xml 1443 1447 <span type="species:ncbi:10366?0.7619047619047619">MCMV</span>
To get further insights into the role of NKG2D and its adapters in resistance to mousepox, we determined cell numbers and virus titers 7 d PI in NKG2D-blocked as well as in DAP12- and DAP10-deficient mice. Results showed that NKG2D blockade and DAP12- or DAP10-deficiency resulted in significantly decreased splenic lymphocytosis as compared with wild type, untreated B6 mice (Figure 3A). More important, the viral loads in NKG2D-blocked mice were almost 103 times higher than in unblocked mice, whereas those of DAP12- and DAP10-deficient mice were also significantly elevated, but to a lesser degree (102 and 10 times higher, respectively) (Figure 3B). Thus, the degree of splenic lymphocytosis and viral loads on day 7 PI was consistent with the lethality and symptoms of mousepox that we observed under the different conditions. Together, these results show that NKG2D is involved in resistance to mousepox. The data also suggest that for this process NKG2D preferentially, but not exclusively, uses DAP12 as the signaling adapter. Most likely, the absence of one adapter is partially compensated by the presence of the other. The data further suggest that Ly49H and Ly49D are not essential for B6 resistance to mousepox because DAP12-deficient mice were only mildly susceptible to mousepox infection. This contrasts with prior studies demonstrating that DAP12-deficient mice on a B6 MCMV-resistant background are exquisitely sensitive to MCMV infection [41].
###end p 43
###begin title 44
###xml 50 58 <span type="species:ncbi:12643">Mousepox</span>
NKG2D Uses DAP10 or DAP12 Adapters to Help Resist Mousepox
###end title 44
###begin p 45
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 52 56 <span type="species:ncbi:12643">ECTV</span>
###xml 247 251 <span type="species:ncbi:10090">mice</span>
(A) The indicated mice were infected with 3,000 pfu ECTV and the absolute number of lymphocytes in their spleens was determined on day 7 PI by trypan blue exclusion. An uninfected control is also shown. Data are the average +/- SD of three pooled mice per group from at least three individual experiments.
###end p 45
###begin p 46
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
(B) Virus titers in spleen of the indicated mice on day 7 PI. Data are the average +/- SD of three pooled mice per group from at least three individual experiments.
###end p 46
###begin title 47
NK Cells Require NKG2D to Control Early Virus Dissemination and to Mediate Optimal Cytotoxicity
###end title 47
###begin p 48
###xml 32 34 32 34 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b042">42</xref>
###xml 249 257 249 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0040030-g004">Figure 4</xref>
###xml 379 383 379 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 83 87 <span type="species:ncbi:10366?0.7619047619047619">MCMV</span>
###xml 177 181 <span type="species:ncbi:12643">ECTV</span>
###xml 354 358 <span type="species:ncbi:12643">ECTV</span>
NKG2D is expressed by NK cells [42] and its expression is further increased during MCMV infection (J. Sun and L. L. Lanier, unpublished data). We, therefore, determined whether ECTV infection also increased NKG2D expression on NK cells. As shown in Figure 4A, NK cells increased NKG2D expression at the cell surface, and the proliferating NK cells after ECTV infection were NKG2Dhigh.
###end p 48
###begin title 49
NK Cells Require NKG2D to Control Early Virus Dissemination and for Optimal Cytotoxicity but Not Activation
###end title 49
###begin p 50
###xml 170 171 164 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 177 178 171 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
###xml 41 45 <span type="species:ncbi:12643">ECTV</span>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
(A) B6 mice were infected with 3,000 pfu ECTV. On day 5 PI, mice were pulsed with BrdU for 3 h and their spleens analyzed by flow cytometry. Plots are gated on CD3epsilon- NK1.1+ cells. Data correspond to pools of three mice from three individual experiments.
###end p 50
###begin p 51
###xml 39 43 <span type="species:ncbi:10090">mice</span>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
###xml 293 297 <span type="species:ncbi:12643">ECTV</span>
###xml 406 410 <span type="species:ncbi:10090">mice</span>
(B) Increased viral titers of infected mice with NKG2D blockade in vivo. Intact B6 mice, B6 mice with NKG2D blockade, B6 mice depleted of NK cells, B6 mice depleted of T cells (treated with anti-CD4 + anti-CD8 mAbs), or depleted of T cells and with NKG2D blockade were infected with 3,000 pfu ECTV and the viral titers in spleen were determined on day 3 PI. Data are the average +/- SD of three individual mice and are representative of two similar experiments.
###end p 51
###begin p 52
###xml 179 180 179 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 186 187 186 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 324 325 320 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 337 338 327 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 52 56 <span type="species:ncbi:12643">ECTV</span>
###xml 236 240 <span type="species:ncbi:10090">mice</span>
###xml 399 403 <span type="species:ncbi:10090">mice</span>
(C) The indicated mice were infected with 3,000 pfu ECTV, and the NK responses in the D-LN were determined at 2 d PI. Upper panel: Dot plot showing the proportion of NK cells (DX5+, CD3e-) in the D-LN of infected and control uninfected mice. Lower panel: GzB and IFN-gamma production by NK cells. Cells correspond to the DX5+, CD3epsilon- gate of the upper panels. Data correspond to pools of three mice and are representative of three similar experiments.
###end p 52
###begin p 53
###xml 52 56 <span type="species:ncbi:12643">ECTV</span>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 192 196 <span type="species:ncbi:10090">mice</span>
###xml 217 221 <span type="species:ncbi:10090">mice</span>
(D) NK cells were purified from spleens (5 d PI) of ECTV-infected intact or NKG2D-blocked mice and stained as indicated. Filled histogram: isotype-matched control Ig; gray line: NKG2D-blocked mice; black line: intact mice.
###end p 53
###begin p 54
###xml 121 123 121 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">51</sup>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
(E) NK cells were purified from spleens of intact or NKG2D-blocked mice as indicated and were used as effectors in a 4-h 51Cr release assay against the indicated targets. Data correspond to pools of three mice and are representative of three experiments.
###end p 54
###begin p 55
###xml 61 65 <span type="species:ncbi:10090">mice</span>
(F) As in (D), but the NK cells were purified from untreated mice and a neutralizing anti-NKG2D mAb was added to the in vitro cytotoxicity assays, as indicated.
###end p 55
###begin p 56
###xml 753 761 753 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0040030-g004">Figure 4</xref>
###xml 193 201 <span type="species:ncbi:12643">mousepox</span>
###xml 353 361 <span type="species:ncbi:12643">mousepox</span>
###xml 550 554 <span type="species:ncbi:10090">mice</span>
###xml 672 676 <span type="species:ncbi:10090">mice</span>
###xml 814 818 <span type="species:ncbi:10090">mice</span>
###xml 886 890 <span type="species:ncbi:10090">mice</span>
###xml 940 944 <span type="species:ncbi:10090">mice</span>
###xml 1067 1075 <span type="species:ncbi:12643">mousepox</span>
The data above showed that NK cells are the main population-controlling early virus dissemination to visceral organs, and that absence of NKG2D signaling results in increased susceptibility to mousepox. However, NKG2D is not only expressed by NK cells but also by some T cells. We hypothesized that if NKG2D has a role in NK cell-mediated resistance to mousepox, NKG2D blockade should result in increased early virus dissemination to organs independent of T cells. To test this hypothesis, we measured early viral titers in the spleens (day 3 PI) of mice treated with the anti-NKG2D mAb CX5. To rule out a role of NKG2D on T cells at this time, we also included groups of mice that were T cell-depleted or NKG2D-blocked and T cell-depleted. As shown in Figure 4B, NKG2D-blocked and T cell-depleted + NKG2D-blocked mice had virus titers that were comparable to those of NK cell-depleted mice and that were significantly higher than those of mice that were only T cell-depleted. Together, these data indicate that NKG2D is involved in the NK cell-mediated resistant to mousepox.
###end p 56
###begin p 57
###xml 115 123 115 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0040030-g004">Figure 4</xref>
###xml 187 195 183 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0040030-g004">Figure 4</xref>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
###xml 448 452 <span type="species:ncbi:10090">mice</span>
###xml 534 538 <span type="species:ncbi:12643">ECTV</span>
We next tested whether NKG2D blockade and DAP10- or DAP12-deficiency affected the recruitment of NK cells to D-LN (Figure 4C, upper panels) or their ability to produce IFN-gamma and GzB (Figure 4C, lower panels). However, we found that none of these parameters were decreased. In fact, in both DAP10- and DAP12-deficient mice more NK cells were recruited to the D-LN and a larger proportion produced IFN-gamma and GzB as compared with wild-type B6 mice. This indicates that NKG2D is required for effective NK cell-mediated control of ECTV, but is not required for their activation.
###end p 57
###begin p 58
###xml 123 131 123 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0040030-g004">Figure 4</xref>
###xml 603 611 603 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0040030-g004">Figure 4</xref>
###xml 648 650 648 650 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">51</sup>
###xml 972 974 972 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b043">43</xref>
###xml 975 977 975 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b044">44</xref>
###xml 1489 1497 1489 1497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0040030-g004">Figure 4</xref>
###xml 1662 1670 1662 1670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0040030-g004">Figure 4</xref>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
###xml 355 359 <span type="species:ncbi:10090">mice</span>
###xml 379 383 <span type="species:ncbi:12643">ECTV</span>
###xml 597 601 <span type="species:ncbi:10090">mice</span>
###xml 720 724 <span type="species:ncbi:12643">ECTV</span>
###xml 1027 1031 <span type="species:ncbi:10090">mice</span>
###xml 1046 1050 <span type="species:ncbi:12643">ECTV</span>
###xml 1163 1167 <span type="species:ncbi:10090">mice</span>
###xml 1262 1266 <span type="species:ncbi:10090">mice</span>
###xml 1385 1389 <span type="species:ncbi:10090">mice</span>
###xml 1537 1541 <span type="species:ncbi:12643">ECTV</span>
###xml 1558 1562 <span type="species:ncbi:10090">mice</span>
###xml 1680 1684 <span type="species:ncbi:12643">ECTV</span>
###xml 1913 1917 <span type="species:ncbi:12643">ECTV</span>
###xml 2101 2105 <span type="species:ncbi:10090">mice</span>
###xml 2217 2221 <span type="species:ncbi:12643">ECTV</span>
Because NK cell recruitment and activation in the D-LN was not diminished by NKG2D blockade or DAP12 and DAP10 deficiency (Figure 4C), we hypothesized that NKG2D may be required for optimal NK cell-mediated cytotoxicity. Thus, we examined whether NK cells from NKG2D-blocked mice were defective in their ability to kill various targets. For this purpose, mice were infected with ECTV and treated or not with anti-NKG2D Ab. Five days later, NK cells were purified from their spleens and immediately analyzed by flow cytometry to confirm NKG2D receptor blockade or downregulation in the CX5-treated mice (Figure 4D) and were used as effectors in 4-h 51Cr release assays. Because we were unable to show specific killing of ECTV-infected cells in vitro, we tested the purified NK cells against a variety of uninfected targets that constitutively express NKG2D ligands at their cell surface (MC57G, MEF, and YAC-1) or, as a control, CHO-K1 whose killing is dependent on Ly49D [43,44], but not NKG2D. We found that the NK cells from mice infected with ECTV (whether treated with anti-NKG2D Ab or not) killed all targets much more effectively than those from uninfected mice. This enhanced killing did not require the targets to be infected. However, the NK cells from mice treated with CX5 were less effective killers of NKG2D ligand-bearing target cells as compared to those from untreated mice, except against CHO-K1 cells for which the NK cell killing is dependent on Ly49D and not on NKG2D (Figure 4E). Furthermore, purified NK cells from ECTV-infected intact mice also demonstrated reduced, but not absent cytotoxicity when anti-NKG2D mAb was added to the assay (Figure 4F). Thus, ECTV infection enhances spontaneous NK cell-mediated cytotoxicity, which is partially reduced by NKG2D blockade. Together, these data suggest that NKG2D signaling is not required for the recruitment and activation of NK cells during ECTV infection, but contributes to their optimal ability to kill targets expressing NKG2D ligands. Because anti-NKG2D did not reduce cytotoxicity to the same levels as those in uninfected mice, the data also indicate that activating receptors other than NKG2D are involved in the cytotoxicity induced by ECTV infection.
###end p 58
###begin title 59
###xml 0 4 <span type="species:ncbi:12643">ECTV</span>
ECTV Infection Upregulates NKG2D Ligands In Vitro and In Vivo
###end title 59
###begin p 60
###xml 342 344 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b045">45</xref>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b049">49</xref>
###xml 834 836 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b050">50</xref>
###xml 839 847 839 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0040030-g005">Figure 5</xref>
###xml 953 961 953 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0040030-g005">Figure 5</xref>
###xml 1405 1413 1405 1413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0040030-g005">Figure 5</xref>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
###xml 366 370 <span type="species:ncbi:12643">ECTV</span>
###xml 436 441 <span type="species:ncbi:10090">mouse</span>
###xml 486 490 <span type="species:ncbi:12643">ECTV</span>
###xml 680 684 <span type="species:ncbi:12643">ECTV</span>
###xml 803 808 <span type="species:ncbi:10090">mouse</span>
###xml 875 879 <span type="species:ncbi:12643">ECTV</span>
###xml 1336 1340 <span type="species:ncbi:12643">ECTV</span>
###xml 1350 1354 <span type="species:ncbi:10090">mice</span>
###xml 1447 1451 <span type="species:ncbi:12643">ECTV</span>
###xml 1647 1651 <span type="species:ncbi:12643">ECTV</span>
NKG2D-mediated killing requires the recognition of ligands on the surface of target cells. The ligands of NKG2D are host cell-encoded MHC class I-like proteins that are expressed by tumors and stressed cells and also following infection of cells with some viruses. Identified cellular ligands for NKG2D in mice include H60, MULT1, and Rae-1 [45-49]. To determine if ECTV infection induces the upregulation of NKG2D ligands, we infected mouse embryo fibroblasts (MEFs) with 0.5 pfu/cell ECTV expressing enhanced green fluorescence protein (EGFP), and the expression of NKG2D ligands on infected and uninfected cells was determined by flow cytometry. Consistent with the ability of ECTV-activated NK cells to spontaneously kill them, MEFs constitutively express NKG2D ligands as revealed by staining with mouse NKG2D-Fc fusion protein [50] (Figure 5A). However, infection with ECTV increased NKG2D-Fc staining and resulted in clear upregulation of MULT1 (Figure 5A) but not Rae-1 (data not shown). We also observed increased staining with NKG2D-Fc and anti-pan Rae-1 and anti-MULT1 mAbs in the fibrosarcoma cell line MC57G, and an increase in staining with NKG2D-Fc and anti-pan Rae-1 mAb in peritoneal lymphocytes (data not shown). Moreover, using quantitative RT-PCR, we detected a 2.8-fold increase of Rae-1 transcripts in the D-LN of ECTV-infected mice at 12 h PI, as compared with uninfected controls (Figure 5C). Thus, these results show that ECTV infection can induce the expression of NKG2D ligands, suggesting that binding of NKG2D with these ligands might result in improved NK cell killing of infected cells in vivo and better control of ECTV dissemination.
###end p 60
###begin title 61
###xml 0 4 <span type="species:ncbi:12643">ECTV</span>
ECTV Infection Induces Increased Expression of NKG2D Ligands In Vitro and In Vivo
###end title 61
###begin p 62
###xml 150 151 150 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 179 180 179 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 36 40 <span type="species:ncbi:12643">ECTV</span>
(A) MEFs were infected with 0.5 pfu ECTV 189898-p7.5-EGFP for 18 h. Cells were analyzed for staining with the indicated reagents after gating for EGFP- cells (uninfected) and EGFP+ cells (infected). Data correspond to one typical experiment from three similar experiments. Shaded area, infected cells stained with isotype-matched control Ig or secondary Ab alone; black line, infected cells stained with the indicated reagent; gray line, non-infected cells stained with the indicated reagent.
###end p 62
###begin p 63
(B) qRT-PCR was performed as described. Data were normalized to the amount of beta-actin mRNA. Data are representative of two similar experiments.
###end p 63
###begin title 64
Discussion
###end title 64
###begin p 65
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b015">15</xref>
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b017">17</xref>
###xml 112 120 <span type="species:ncbi:12643">mousepox</span>
In this study, we confirmed previous reports demonstrating that NK cells are required for natural resistance to mousepox [15-17]. More importantly, we define several of the mechanisms whereby NK cells afford this resistance.
###end p 65
###begin p 66
###xml 607 609 607 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b051">51</xref>
###xml 610 612 610 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b052">52</xref>
###xml 640 641 640 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</italic>
###xml 937 939 929 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b017">17</xref>
###xml 1013 1015 1005 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b053">53</xref>
###xml 1698 1700 1682 1684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b017">17</xref>
###xml 2037 2038 2013 2014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b006">6</xref>
###xml 2039 2041 2015 2017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b015">15</xref>
###xml 2042 2044 2018 2020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b017">17</xref>
###xml 70 78 <span type="species:ncbi:12643">mousepox</span>
###xml 91 95 <span type="species:ncbi:10090">mice</span>
###xml 385 393 <span type="species:ncbi:12643">mousepox</span>
###xml 460 468 <span type="species:ncbi:12643">mousepox</span>
###xml 713 721 <span type="species:ncbi:12643">mousepox</span>
###xml 730 734 <span type="species:ncbi:12643">ECTV</span>
###xml 748 752 <span type="species:ncbi:10090">mice</span>
###xml 825 829 <span type="species:ncbi:10090">mice</span>
###xml 861 869 <span type="species:ncbi:12643">mousepox</span>
###xml 931 935 <span type="species:ncbi:10090">mice</span>
###xml 1546 1550 <span type="species:ncbi:12643">ECTV</span>
###xml 1580 1584 <span type="species:ncbi:10090">mice</span>
###xml 1661 1665 <span type="species:ncbi:10090">mice</span>
###xml 1688 1696 <span type="species:ncbi:12643">mousepox</span>
###xml 1835 1839 <span type="species:ncbi:12643">ECTV</span>
###xml 2027 2035 <span type="species:ncbi:12643">mousepox</span>
###xml 2511 2519 <span type="species:ncbi:12643">mousepox</span>
To determine whether and when NK cells are required for resistance to mousepox we depleted mice of NK cells with either anti-asialo GM1 or anti-NK1.1 Abs at different times PI. Although separately these two approaches have caveats, together they provide conclusive evidence that the presence of NK cells during the first 4 d PI, but not beyond day 5 PI, is essential for resistance to mousepox. First, even though anti-NK1.1 Ab depletes NKT cells, the loss of mousepox resistance upon Ab treatment cannot be due to the elimination of NKT cells because anti-asialo GM1 Ab does not eliminate this population [51,52]. Furthermore, Parker et al. recently demonstrated that NKT cells are dispensable for resistance to mousepox because ECTV infection of mice deficient in NKT cells (i.e., CD1d- and Valpha14Jalpha281 TCR-deficient mice) did not result in symptoms of mousepox or an increase in virus titers when compared to wild-type B6 mice [17]. Second, although anti-asialo GM1 can eliminate some activated T cells [53], the loss of resistance cannot be attributed to T cell depletion because asialo GM1 is not expressed on virus-specific T cells within the first few days after viral infection. Moreover, we show that anti-NK1.1 and -asialo GM1 Abs do not affect resistance when given on day 6 PI (the peak of the T cell response). Furthermore, treatment with anti-NK1.1, but not depletion of T cells one day before infection, resulted in significantly increased virus titers on day 3 PI. In addition, treatment with anti-asialo GM1 Ab accelerated ECTV lethality in RAG-1-deficient mice, which lack adaptive immunity (data not shown). gammadelta T cell-deficient mice are also resistant to mousepox [17], indicating that the possible depletion of some gammadelta T cells by anti-asialo GM1 Ab cannot account for the dramatic increase in ECTV lethality after treatment with this Ab. Although work in other laboratories has already shown that depletion of NK cells with either anti-NK1.1 or asialo-GM1 results in susceptibility to mousepox [6,15,17], depletion at different times PI has not been described previously. Sequential depletion of NK cells allowed us to establish that the presence of NK cells is required only during the very early stages of infection. This is consistent with the concept that NK cells serve as the first line of defense after infection, thereby providing sufficient time to mount a full-fledged T and B cell response. We also established, however, that the contribution of NK cells to mousepox resistance extends beyond the need for their physical presence to kill virus-infected cells early after infection because NK cell depletion before day 4 PI resulted in higher virus titers and death after this time. This is most likely due to the role of NK cells in allowing a potent antiviral T cell response to develop, as discussed below.
###end p 66
###begin p 67
###xml 1293 1294 1293 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b005">5</xref>
###xml 1295 1297 1295 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b054">54</xref>
###xml 1298 1300 1298 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b056">56</xref>
###xml 1379 1380 1379 1380 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1564 1566 1564 1566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b054">54</xref>
###xml 1801 1803 1801 1803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b054">54</xref>
###xml 95 99 <span type="species:ncbi:12643">ECTV</span>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 1260 1264 <span type="species:ncbi:12643">ECTV</span>
###xml 1335 1343 <span type="species:ncbi:12643">mousepox</span>
###xml 1363 1367 <span type="species:ncbi:10090">mice</span>
###xml 1402 1410 <span type="species:ncbi:12643">mousepox</span>
###xml 1455 1459 <span type="species:ncbi:12643">ECTV</span>
We also followed the kinetics of NK proliferation and activation in spleen, liver, and D-LN of ECTV-infected mice. Interestingly, although we detected some proliferation, we did not find activated NK cells in liver and spleen on day 3 PI. This was despite the fact that NK cell-mediated control of virus loads in spleen and liver already occurred at this time PI. In fact, the peak of NK cell activation in spleen and liver took place on day 5 PI. On the other hand, the proportion of total NK cells, as well as the proportion of activated NK cells in the D-LN, peaked as early as day 2 PI, and these parameters were still substantially elevated on day 3 PI, notwithstanding that the proliferation of NK cells at these times was not yet detectable in D-LN. In addition, we found that the increase in NK cell numbers in the D-LN on day 2 PI was mostly due to an increase in mature NK cells and that these mature NK cells were preferentially activated. Together, these data suggest that the prompt NK cell response in the D-LN is responsible for the early control of virus loads in central organs and that this response is mostly due to the recruitment and activation of mature NK cells rather than their expansion. To spread to central organs from the footpad, ECTV must pass through the D-LN [5,54-56]. Recently, we have shown that in mousepox-susceptible BALB/c mice, memory CD8+ T cells protect from mousepox, at least in part, by curbing the spread of ECTV from the D-LN to central organs and allowing for the establishment of a full-fledged adaptive response [54]. Our results here suggest that NK cells may use the same strategy, furthering a model where LNs are not only sites where lymphocytes are primed and proliferate but also the place where a major fight against virus spread takes place [54].
###end p 67
###begin p 68
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b025">25</xref>
###xml 1008 1010 1004 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b028">28</xref>
###xml 2008 2009 2000 2001 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2027 2029 2019 2021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b057">57</xref>
###xml 90 98 <span type="species:ncbi:12643">mousepox</span>
###xml 174 178 <span type="species:ncbi:12643">ECTV</span>
###xml 366 370 <span type="species:ncbi:10090">mice</span>
###xml 550 558 <span type="species:ncbi:12643">mousepox</span>
###xml 1095 1099 <span type="species:ncbi:12643">ECTV</span>
###xml 1109 1117 <span type="species:ncbi:12643">mousepox</span>
###xml 1148 1152 <span type="species:ncbi:10090">mice</span>
###xml 1172 1176 <span type="species:ncbi:10090">mice</span>
###xml 1219 1223 <span type="species:ncbi:10090">mice</span>
###xml 1270 1274 <span type="species:ncbi:12643">ECTV</span>
###xml 1694 1702 <span type="species:ncbi:12643">mousepox</span>
###xml 1722 1726 <span type="species:ncbi:10090">mice</span>
###xml 1762 1766 <span type="species:ncbi:12643">ECTV</span>
###xml 1927 1941 <span type="species:ncbi:10245">vaccinia virus</span>
###xml 1972 1976 <span type="species:ncbi:12643">ECTV</span>
In addition to NK cells, strong adaptive T cell responses are essential for resistance to mousepox. Our experiments here show that NK cells have a direct role in controlling ECTV because they reduced virus loads on day 3 PI when the T cell response is still undetectable (data not shown and [25]). However, if the only role of NK cells were direct, one would expect mice depleted of NK cells to become sick, but recover once the adaptive immune system takes control. Yet, while the presence of NK cells on day 6 PI was not required for resistance to mousepox, their presence before day 6 PI was vital for controlling virus titers and preventing pathology and death after this time. This could be explained by the finding that depletion of NK cells on the day of infection resulted in a substantially reduced T cell response. There are three non-excluding possibilities that may explain this effect. First, NK cell production of cytokines such as IFN-gamma may directly modulate the adaptive T cell response [28]. A caveat to this hypothesis is that NK cells produce as much or more IFN-gamma in ECTV-infected mousepox-susceptible BALB/c and DBA2/J mice as in resistant B6 mice (unpublished data), but these susceptible mice fail to mount an effective T cell response to ECTV. Second, NK cells may indirectly affect the activation of T cells through their interaction with antigen-presenting cells such as macrophages and dendritic cells (DC). This hypothesis has the same caveats as the one above. Third, it is possible that in the absence of NK cells, the uncontrolled virus replication of a highly pathogenic virus overwhelms the T cell response. In support of this possibility, infection of mousepox-susceptible BALB/c mice with a highly attenuated strain of ECTV results in the induction of a strong T cell response (unpublished data), and depletion of NK cells does not affect the T cell response to the poorly pathogenic vaccinia virus (unpublished data) with which ECTV shares most of the dominant CD8+ T cell epitopes [57].
###end p 68
###begin p 69
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rmp1</italic>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b016">16</xref>
###xml 183 187 183 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rmp1</italic>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b024">24</xref>
###xml 891 893 891 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b028">28</xref>
###xml 1023 1024 1023 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</italic>
###xml 1114 1116 1114 1116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b058">58</xref>
###xml 1445 1447 1445 1447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b059">59</xref>
###xml 92 100 <span type="species:ncbi:12643">mousepox</span>
###xml 271 279 <span type="species:ncbi:12643">mousepox</span>
###xml 484 492 <span type="species:ncbi:12643">mousepox</span>
###xml 502 506 <span type="species:ncbi:12643">ECTV</span>
###xml 709 712 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 765 770 <span type="species:ncbi:10090">mouse</span>
###xml 775 780 <span type="species:ncbi:9606">human</span>
###xml 781 784 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1050 1062 <span type="species:ncbi:10243">cowpox virus</span>
###xml 1175 1179 <span type="species:ncbi:12643">ECTV</span>
###xml 1181 1185 <span type="species:ncbi:10245">VACV</span>
###xml 1406 1410 <span type="species:ncbi:10245">VACV</span>
###xml 1429 1434 <span type="species:ncbi:9606">human</span>
###xml 1551 1556 <span type="species:ncbi:9606">human</span>
###xml 1564 1569 <span type="species:ncbi:10090">mouse</span>
Previous work by Delano and Brownstein showed that Rmp1, a gene important for resistance to mousepox, maps to the NK complex in distal chromosome 6 [16]. Moreover, they proposed that Rmp1 encoded NK1.1 [24]. However, we found that NK1.1 is not required for resistance to mousepox. In addition, our work suggests that the activating receptors Ly49D and Ly49H are likely not involved. On the other hand, using in vivo signaling blockade we found that NKG2D is involved in resistance to mousepox and that ECTV infection results in the upregulation of NKG2D ligands in vivo and in vitro. That NKG2D is involved in antiviral responses has precedents. For example, previous studies have shown that cytomegalovirus (CMV) induces the upregulation of NKG2D ligands and that mouse and human CMV encode immune evasion molecules that downregulate NKG2D ligands and are important for their pathogenesis [28]. However, a direct role for NKG2D in the response to poxviruses has not been described previously. Interestingly, Campbell et al. have recently shown that cowpox virus encodes a soluble competitive antagonist of NKG2D [58]. Although this gene has been lost in other OPVs, such as ECTV, VACV, VARV, and MPXV, these data support our finding that NKG2D is involved in resistance to some OPV infections. On the other hand, NKp30, NKp44, and NKp46, but not NKG2D, were found to be responsible for the recognition of VACV-infected cells by human NK cells [59]. Whether this reflects differences between NK cell recognition of different OPVs, differences between human versus mouse NK cells, or both, will require further investigation.
###end p 69
###begin p 70
###xml 8 13 <span type="species:ncbi:10090">mouse</span>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
###xml 330 334 <span type="species:ncbi:10090">mice</span>
###xml 374 382 <span type="species:ncbi:12643">mousepox</span>
###xml 536 540 <span type="species:ncbi:10090">mice</span>
###xml 566 574 <span type="species:ncbi:12643">mousepox</span>
###xml 596 600 <span type="species:ncbi:10090">mice</span>
###xml 698 706 <span type="species:ncbi:12643">mousepox</span>
###xml 764 768 <span type="species:ncbi:10090">mice</span>
###xml 800 808 <span type="species:ncbi:12643">mousepox</span>
###xml 831 835 <span type="species:ncbi:10090">mice</span>
Because mouse NKG2D signals through either the adapter protein DAP12 or DAP10, we further tested the susceptibility of mice lacking one or the other adapter. Of interest, when considering virus titers and spleen cellularity, the susceptibility of these two strains of mice was intermediate between intact and NKG2D mAb-blocked B6 mice. This indicates that for resistance to mousepox, the two adapters likely have overlapping, but not completely redundant, effects. Still, DAP12 seems to be the preferred adapter because DAP12-deficient mice were more susceptible to mousepox than DAP10-deficient mice, although it is possible that other DAP12-associated receptors might contribute to resistance to mousepox. Our results predict that DAP10 + DAP12 double-deficient mice would be highly susceptible to mousepox. Unfortunately, these mice are not yet available.
###end p 70
###begin p 71
###xml 61 62 61 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 168 169 168 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 106 110 <span type="species:ncbi:12643">ECTV</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 355 363 <span type="species:ncbi:12643">mousepox</span>
###xml 523 527 <span type="species:ncbi:12643">ECTV</span>
###xml 713 717 <span type="species:ncbi:12643">ECTV</span>
###xml 848 852 <span type="species:ncbi:12643">ECTV</span>
###xml 1106 1110 <span type="species:ncbi:10090">mice</span>
###xml 1126 1134 <span type="species:ncbi:12643">mousepox</span>
###xml 1296 1300 <span type="species:ncbi:12643">ECTV</span>
###xml 1310 1314 <span type="species:ncbi:10090">mice</span>
###xml 1423 1427 <span type="species:ncbi:12643">ECTV</span>
###xml 1605 1613 <span type="species:ncbi:12643">mousepox</span>
NKG2D is expressed by most NK cells but also by activated CD8+ T cells. In fact, we have observed that in ECTV-infected B6 mice a large proportion of virus-specific CD8+ T cells express NKG2D beginning 7 d PI (unpublished data). Thus, the experiments reported here do not rule out the additional contribution of NKG2D in the T cell-mediated resistance to mousepox, a very interesting possibility that we are currently investigating. Nevertheless, our experiments clearly implicate NKG2D in the NK cell-mediated response to ECTV because in vivo NKG2D blockade resulted in enhanced virus loads in central organs before the onset of the T cell response and because in vivo NKG2D blockade reduced the cytotoxicity of ECTV-activated NK cells. Still, several lines of evidence indicate that NKG2D is not the only activating receptor involved in the anti-ECTV NK cell-mediated response and that its most likely role is as a co-stimulator that facilitates cytotoxicity rather than being required for the initial NK cell activation: (1) NK cell depletion was much more effective than NKG2D blockade at rendering B6 mice susceptible to mousepox; (2) NKG2D-blockade did not affect NK cell proliferation (data not shown), IFN-gamma and GzB production by NK cells, or recruitment of NK cells into the D-LN of ECTV-infected mice; (3) In vivo and in vitro NKG2D blockade significantly decreased, but did not abrogate, the cytotoxicity of ECTV-activated NK cells. Ongoing studies in our laboratory are aimed at identifying other activating receptor(s) and signaling pathway(s) required for NK cell-mediated resistance to mousepox.
###end p 71
###begin p 72
###xml 91 95 <span type="species:ncbi:10090">mice</span>
###xml 99 107 <span type="species:ncbi:12643">mousepox</span>
###xml 419 427 <span type="species:ncbi:12643">mousepox</span>
###xml 564 568 <span type="species:ncbi:12643">ECTV</span>
In summary, our work demonstrates that NK cells contribute to the natural resistance of B6 mice to mousepox by using direct effector functions (most likely the killing of infected cells) to curb virus dissemination and by supporting a strong adaptive T cell response. Moreover, our data suggest that the activating receptor NKG2D, but not NK1.1 or Ly49 family members, has a role in this NK cell-mediated resistance to mousepox by promoting optimal NK cell-mediated killing. Thus, our data provide substantial insights into the mechanisms of natural resistance to ECTV and possibly other OPV infections. Together, our work furthers our understanding of host-pathogen interactions and the mechanisms whereby NK cells protect from viral disease.
###end p 72
###begin title 73
Materials and Methods
###end title 73
###begin title 74
Cells.
###end title 74
###begin p 75
###xml 773 774 766 767 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
###xml 367 371 <span type="species:ncbi:9913">calf</span>
###xml 573 577 <span type="species:ncbi:9913">calf</span>
YAC-1 and CHO-K1 cell lines were obtained from Dr. Kerry Campbell (Fox Chase Cancer Center, Philadelphia, Pennsylvania), and A9, MC57G, and BSC-1 cells were obtained from the ATCC. MEF cells were made from day 11 to 13 embryos from B6 mice. As standard tissue culture media, we used RPMI-10 that consisted of RPMI-1640 medium (Invitrogen) supplemented with 10% fetal calf serum (Sigma), 100 IU/ml penicillin and 100 mug/ml streptomycin (Invitrogen), 10 mM Hepes buffer (Invitrogen), and 0.05 mM 2-mercaptoethanol (Sigma). MEF were grown in DMEM medium containing 15% fetal calf serum. When indicated, RPMI 2.5 (as above but with 2.5% FCS) was used. When required, 10 U/ml interleukin 2 (IL2) was added to RPMI 10 (RPMI 10-IL2). All cells were grown at 37 degreesC and 5% CO2.
###end p 75
###begin title 76
###xml 9 13 <span type="species:ncbi:10090">mice</span>
Viruses, mice, and infections.
###end title 76
###begin p 77
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b008">8</xref>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b060">60</xref>
###xml 1551 1552 1545 1546 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1805 1807 1793 1795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b061">61</xref>
###xml 1808 1810 1796 1798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b062">62</xref>
###xml 1880 1882 1868 1870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b063">63</xref>
###xml 2369 2370 2352 2353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 18 22 <span type="species:ncbi:12643">ECTV</span>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 156 160 <span type="species:ncbi:12643">ECTV</span>
###xml 278 282 <span type="species:ncbi:12643">ECTV</span>
###xml 318 322 <span type="species:ncbi:10245">VACV</span>
###xml 379 383 <span type="species:ncbi:12643">ECTV</span>
###xml 602 607 <span type="species:ncbi:10090">mouse</span>
###xml 742 746 <span type="species:ncbi:12643">ECTV</span>
###xml 1282 1286 <span type="species:ncbi:12643">ECTV</span>
###xml 1375 1379 <span type="species:ncbi:12643">ECTV</span>
###xml 1419 1423 <span type="species:ncbi:12643">ECTV</span>
###xml 1505 1509 <span type="species:ncbi:12643">ECTV</span>
###xml 1799 1803 <span type="species:ncbi:10090">mice</span>
###xml 1874 1878 <span type="species:ncbi:10090">mice</span>
###xml 1943 1947 <span type="species:ncbi:10090">mice</span>
###xml 2121 2125 <span type="species:ncbi:10090">mice</span>
###xml 2268 2272 <span type="species:ncbi:12643">ECTV</span>
###xml 2297 2301 <span type="species:ncbi:10090">mice</span>
###xml 2375 2379 <span type="species:ncbi:12643">ECTV</span>
###xml 2403 2407 <span type="species:ncbi:10090">mice</span>
###xml 2607 2611 <span type="species:ncbi:10090">mice</span>
The production of ECTV stocks for infection of mice and the determination of titers in stocks and organs were done as described previously [8]. To generate ECTV 189898-p7.5-EGFP, we adapted the method described by Johnston and McFadden [60]. Briefly, a construct containing the ECTV Moscow fragment 189543-189897, the VACV early/late promoter p7.5, the sequence of EGFP, and the ECTV Moscow fragment 189950-190297, in that order, was made by recombinant PCR and cloned into plasmid Bluescript II SK+ to generate the targeting vector pBS-EVM189898-p7.5-EGFP. This targeting vector was used to transfect mouse A9 cells using Lipofectamine 2000 as per manufacturer's instructions (Invitrogen). The transfected cells were infected with wild-type ECTV (Moscow strain, 0.3 pfu/cell) in 6-well plates. 2 d later, transfected/infected A9 cells were harvested using a rubber policeman, frozen and thawed, and different dilutions of cell lysates were used to infect BSC-1 cells in 6-well plates. 2 h after infection, the cells were overlaid with media containing 0.5% agarose. 4 d later, green-fluorescent plaques were picked with a pipette tip and used to infect a new set of cells. The purification procedure was iterated five times until all plaques were fluorescent. The resulting virus, ECTV 189898-p7.5-EGFP, carries EGFP in a non-coding region and is as pathogenic as wild-type ECTV Moscow (not shown). For preparation of ECTV stock for infection of different cell lines, A9 cells were infected with 0.2 pfu ECTV/cell, and incubated at 37 degreesC, 5% CO2. After 5 d, the cells were collected, frozen and thawed three times, and then sonicated in a water-bath sonicator. The solid material was pelleted by centrifugation, and the supernatant was stored in aliquots at -80 degreesC. The DAP10-deficient mice [61,62] (generously provided by Dr. Joe Phillips) and DAP12-deficient mice [63] on the C57BL/6 background were bred at UCSF. All the other mice were bred at the Fox Chase Cancer Center Laboratory Animal Facility in specific pathogen-free rooms or were purchased from Jackson Laboratories. IFN-gamma-deficient C57BL/6 mice were generously provided by Dr. Glenn Rall. For infections, sex-matched animals 8-12 wk old were transferred to a biosafety level 3 room. For ECTV infection, anesthetized mice were infected in the left footpad with 25 mul PBS containing 3 x 103 pfu ECTV. Following infections, mice were observed daily for signs of disease (lethargy, ruffled hair, weight loss, skin rash, and eye secretions) and imminent death (unresponsiveness to touch and lack of voluntary movements). Moribund mice were euthanized by halothane inhalation. All of the experimental protocols involving animals were approved by the Fox Chase Cancer Center Institutional Animal Care and Use Committee.
###end p 77
###begin p 78
###xml 37 38 37 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 4 8 <span type="species:ncbi:12643">ECTV</span>
###xml 165 169 <span type="species:ncbi:12643">ECTV</span>
###xml 273 277 <span type="species:ncbi:12643">ECTV</span>
###xml 313 317 <span type="species:ncbi:10090">mice</span>
For ECTV infection of cells, 3-5 x 105 cells were plated in 6-well plates and cultured overnight to allow cells to adhere. The cells were then infected with 0.5 pfu ECTV/cell for 18 h, collected, washed, stained, and analyzed for surface expression of various markers. For ECTV infection of peritoneal cells, the mice were euthanized by halothane inhalation and injected i.p. with PBS, the abdomen massaged gently, and the peritoneal cells were collected by aspiration and washed.
###end p 78
###begin title 79
In vivo depletion of NK cells or T cells and NKG2D blockade.
###end title 79
###begin p 80
###xml 258 262 <span type="species:ncbi:10090">mice</span>
###xml 385 389 <span type="species:ncbi:10090">mice</span>
Depletion of NK cells was performed by i.p. inoculation of 200 mug anti-NK1.1 mAb PK136 or 20 mul anti-asialo GM1 antisera (Wako), as indicated. Antibody treatment was done 1 d before or on the indicated days after virus infection. For depletion of T cells, mice were injected i.p. with 200 mug anti-CD4 mAb GK1.5 and 200 mug anti-CD8 mAb 2.43 1 d before infection. For NKG2D blockade mice were inoculated with purified 200 mug CX5 Ab 1 d before and 2 d PI.
###end p 80
###begin title 81
Isolation of liver lymphocytes.
###end title 81
###begin p 82
###xml 312 313 312 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 441 442 441 442 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were exsanguinated from the orbital cavity to decrease the amount of blood in the liver. The liver was removed and passed through a cell strainer (BD Falcon) to obtain a single cell suspension. The cells were resuspended in 35% Percoll solution (in PBS) containing 100 U/ml heparin and centrifuged at 830 x g for 15 min at room temperature. The upper liquid phase was removed from the tube, the lymphocyte pellet resuspended in 0.84% NH4Cl solution to lyse the red blood cells, and then washed twice with medium.
###end p 82
###begin title 83
BrdU incorporation assay.
###end title 83
###begin p 84
###xml 43 47 <span type="species:ncbi:10090">mice</span>
At the indicated time post-infection (PI), mice were injected with 2 mg BrdU i.p. 3 h later, spleens and lymph nodes (LNs) were removed and made into single cell suspensions. The liver lymphocytes were obtained as described above. The cells were then stained for cell surface molecules, fixed, and permeabilized using the Cytofix/Cytoperm kit (BD Pharmingen) according to the manufacturer's instructions, incubated with DNase at 37 degreesC for 1 h, and subsequently stained with FITC-conjugated anti-BrdU mAb (eBiosciences).
###end p 84
###begin title 85
Flow cytometry.
###end title 85
###begin p 86
###xml 97 98 97 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0040030-b008">8</xref>
###xml 438 439 431 432 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 652 656 <span type="species:ncbi:12643">ECTV</span>
###xml 867 870 <span type="species:ncbi:10116">rat</span>
###xml 876 881 <span type="species:ncbi:10090">mouse</span>
###xml 933 936 <span type="species:ncbi:10116">rat</span>
###xml 973 976 <span type="species:ncbi:10116">rat</span>
###xml 982 987 <span type="species:ncbi:10090">mouse</span>
###xml 1048 1054 <span type="species:ncbi:9793">donkey</span>
###xml 1060 1063 <span type="species:ncbi:10116">rat</span>
###xml 1114 1119 <span type="species:ncbi:10090">mouse</span>
###xml 1126 1131 <span type="species:ncbi:9606">human</span>
###xml 1188 1193 <span type="species:ncbi:9606">human</span>
Determination of cytokine production by intracellular staining was done as described previously [8]. To determinate NK cell responses in LNs, intact organs were incubated at 37 degreesC for 1 h in media containing 10 mug/ml brefeldin A, made into single cell suspensions, stained, and analyzed as described above. To evaluate NK cell responses in the spleen, the organs were made into single-cell suspensions, RBC were lysed with 0.84% NH4Cl, and the lymphocytes were washed and incubated at 37 degreesC for 1 h with brefeldin A, followed by staining and analysis as described. To determine expression of NKG2D ligands, MEFs were infected with 0.5 pfu ECTV 189898-p7.5-EGFP for 18 h. Infected cells (approximately15%) were identified by EGFP expression. Gated infected and uninfected cells were analyzed for expression of NKG2D ligands by staining with: a PE-labeled rat anti-mouse Rae-1 (IgG2a isotype, R&D Systems) or a PE-labeled rat isotype-matched control IgG2a; with rat anti-mouse MULT1 (IgG2a isotype, R&D Systems) and secondary PE-labeled donkey anti-rat IgG2a or secondary Ab alone as a control; or with mouse NKG2D-human Fc fusion protein (R&D Systems) and an APC-labeled anti-human IgG (BD) secondary Ab or secondary Ab alone as control.
###end p 86
###begin title 87
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">51</sup>
51Cr release assays.
###end title 87
###begin p 88
###xml 428 430 426 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">51</sup>
###xml 540 541 536 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
NK cells were purified from spleens using anti-CD49b-conjugated microbeads and a LS column (Miltenyi Biotec) according to the manufacturer's instructions and were stained for flow cytometric analysis with PE-conjugated anti-NKG2D mAb CX5. NK cells were resuspended in RPMI 10, and serially diluted in round-bottom 96-well plates in triplicate in 100 mul/well. The indicated target cells were prepared by incubation with 200 mul 51Cr (0.1 mCi) in 100 mul of FCS for 2 h. Cells were thoroughly washed, resuspended in RPMI 10, and 50 mul (5x103 targets) were added to the wells containing effector cells. The plates were incubated at 37 degreesC for 4 h. Where indicated, 20 mug/ml of a neutralizing anti-NKG2D mAb (clone 191004, R&D Systems) was added at the initiation of cytotoxicity assays. 50 mul supernatants were transferred to white 96-well plates containing 75-mul Microscint-40 scintillation fluid (PerkinElmer). Controls included wells with target cells alone for spontaneous release and wells with target cells and 1% Triton-X for maximal release. Radioactivity was measured by using a Packard Topcount instrument (PerkinElmer). Specific lysis was determined by using the formula [(experimental release - spontaneous release)/(full release - spontaneous release)]x100. Three animals were used per experimental group.
###end p 88
###begin title 89
Quantitative real-time PCR (qRT-PCR).
###end title 89
###begin p 90
###xml 518 522 <span type="species:ncbi:10090">mice</span>
Primers and probes for Rae-1 were purchased from Applied Biosystems. The amplicon was 95 bp and the sequence of the probe was GGAAAAGCCAAGATCAACCTCAAGG. The primers and probe for beta-actin were synthesized at the DNA Synthesis Facility in the Fox Chase Cancer Center. The primers and probe used for beta-actin were: sense, 5'-CACCGAGGCCCCCCT-3'; anti-sense, 5'-CAGCCTGGATGGCTACGTACA-3', and the probe was 5'-6-FAM-AACCCTAAGGCCAACCGTGAAAAGATGA-BHQ1-3'. Total RNA extracted from infected cell lines and LNs of infected mice was treated with Dnase I, and the first-strand cDNA was synthesized by using random primers. qRT-PCR was carried out by using the ABI 7500 (Applied Biosystems). The cycling conditions for real-time PCR were: 50 degreesC for 10 min, followed by 45 cycles of 95 degreesC for 30 s, and 60 degreesC for 2 min. Data were analyzed by using the Sequence Detection v1.2 Analysis Software (Applied Biosystems).
###end p 90
###begin title 91
Statistical analysis.
###end title 91
###begin p 92
###xml 21 22 21 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 355 357 355 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-</italic>
We used a two-tailed t test for two samples for means with a confidence level (alpha) of 0.05 using Excel Analysis Tool Pack (Microsoft). Differences in survival and disease were determined at the FCCC Biostatistics and Bioinformatics Facility using Log Rank Test with the STATE SE/9.2 software. In all cases, differences were considered significant when p-values were </= 0.05.
###end p 92
###begin p 93
###xml 305 309 <span type="species:ncbi:10090">mice</span>
We thank FCCC Tissue Culture, Quantitative Real Time PCR, Flow Cytometry, Hybridoma, Biostatistics and Bioinformatics, Histopathology, and Laboratory Animal Facilities. We thank Dr. Andres Klein-Szanto for histopathology analysis, Drs. David Hesslein, Joe Sun, and Mark Orr for assistance with the mutant mice and comments on the manuscript, Drs. Kerry Campbell and Glenn Rall for comments on the manuscript, and Holly Gillin for secretarial assistance.
###end p 93
###begin title 94
References
###end title 94
###begin article-title 95
###xml 24 40 <span type="species:ncbi:12643">ectromelia virus</span>
###xml 65 73 <span type="species:ncbi:12643">mousepox</span>
The genomic sequence of ectromelia virus, the causative agent of mousepox
###end article-title 95
###begin article-title 96
Monkeypox in the United States: an occupational health look at the first cases
###end article-title 96
###begin article-title 97
Monkeypox in the Western hemisphere
###end article-title 97
###begin article-title 98
###xml 0 16 <span type="species:ncbi:12643">Ectromelia virus</span>
###xml 41 49 <span type="species:ncbi:12643">mousepox</span>
Ectromelia virus: the causative agent of mousepox
###end article-title 98
###begin article-title 99
###xml 0 8 <span type="species:ncbi:12643">Mousepox</span>
Mousepox (ectromelia)
###end article-title 99
###begin article-title 100
Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection
###end article-title 100
###begin article-title 101
Poxvirus pathogenesis
###end article-title 101
###begin article-title 102
Antibodies and CD8+ T cells are complementary and essential for natural resistance to a highly lethal cytopathic virus
###end article-title 102
###begin article-title 103
Natural killer cells and viral infections
###end article-title 103
###begin article-title 104
Natural killer cells in antiviral defense: function and regulation by innate cytokines
###end article-title 104
###begin article-title 105
Severe herpesvirus infections in an adolescent without natural killer cells
###end article-title 105
###begin article-title 106
Familial NK cell deficiency associated with impaired IL-2- and IL-15-dependent survival of lymphocytes
###end article-title 106
###begin article-title 107
Fatal varicella associated with selective natural killer cell deficiency
###end article-title 107
###begin article-title 108
###xml 16 38 <span type="species:ncbi:10366">murine cytomegalovirus</span>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice
###end article-title 108
###begin article-title 109
###xml 99 115 <span type="species:ncbi:12643">ectromelia virus</span>
Evidence that NK cells and interferon are required for genetic resistance to lethal infection with ectromelia virus
###end article-title 109
###begin article-title 110
###xml 28 36 <span type="species:ncbi:12643">mousepox</span>
Innate resistance to lethal mousepox is genetically linked to the NK gene complex on Chromosome 6 and correlates with early restriction of virus replication by cells with an NK phenotype
###end article-title 110
###begin article-title 111
###xml 46 62 <span type="species:ncbi:12643">ectromelia virus</span>
Induction of natural killer cell responses by ectromelia virus controls infection
###end article-title 111
###begin article-title 112
Physiologic functions of activating natural killer (NK) complex-encoded receptors on NK cells
###end article-title 112
###begin article-title 113
NK cell recognition
###end article-title 113
###begin article-title 114
Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors
###end article-title 114
###begin article-title 115
###xml 0 22 <span type="species:ncbi:10366">Murine cytomegalovirus</span>
Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H
###end article-title 115
###begin article-title 116
Recognition of a virus-encoded ligand by a natural killer cell activation receptor
###end article-title 116
###begin article-title 117
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily
###end article-title 117
###begin article-title 118
###xml 36 44 <span type="species:ncbi:12643">mousepox</span>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
Differential pathogenesis of lethal mousepox in congenic DBA/2 mice implicates natural killer cell receptor NKR-P1 in necrotizing hepatitis and the fifth component of complement in recruitment of circulating leukocytes to spleen
###end article-title 118
###begin article-title 119
Direct CD28 costimulation is required for CD8+ T cell-mediated resistance to an acute viral disease in a natural host
###end article-title 119
###begin article-title 120
###xml 22 27 <span type="species:ncbi:10090">mouse</span>
Functional subsets of mouse natural killer cells
###end article-title 120
###begin article-title 121
CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity
###end article-title 121
###begin article-title 122
Viral modulation of NK cell immunity
###end article-title 122
###begin article-title 123
###xml 37 53 <span type="species:ncbi:12643">ectromelia virus</span>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
Perforin is essential for control of ectromelia virus but not related poxviruses in mice
###end article-title 123
###begin article-title 124
###xml 43 51 <span type="species:ncbi:12643">mousepox</span>
Importance of interferons in recovery from mousepox
###end article-title 124
###begin article-title 125
Obligatory requirement for antibody in recovery from a primary poxvirus infection
###end article-title 125
###begin article-title 126
FcR gamma chain deletion results in pleiotrophic effector cell defects
###end article-title 126
###begin article-title 127
Association with FcRgamma is essential for activation signal through NKR-P1 (CD161) in natural killer (NK) cells and NK1.1+ T cells
###end article-title 127
###begin article-title 128
###xml 58 62 <span type="species:ncbi:10090">mice</span>
Impairment of NK cell function by NKG2D modulation in NOD mice
###end article-title 128
###begin article-title 129
###xml 51 55 <span type="species:ncbi:10090">mice</span>
NKG2D blockade prevents autoimmune diabetes in NOD mice
###end article-title 129
###begin article-title 130
NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules
###end article-title 130
###begin article-title 131
The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions
###end article-title 131
###begin article-title 132
Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D
###end article-title 132
###begin article-title 133
NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation
###end article-title 133
###begin article-title 134
Natural killer cell receptor signaling
###end article-title 134
###begin article-title 135
###xml 95 117 <span type="species:ncbi:10366">murine cytomegalovirus</span>
Pivotal role of KARAP/DAP12 adaptor molecule in the natural killer cell-mediated resistance to murine cytomegalovirus infection
###end article-title 135
###begin article-title 136
The role of the NKG2D immunoreceptor in immune cell activation and natural killing
###end article-title 136
###begin article-title 137
Genetic control of natural killing and in vivo tumor elimination by the Chok locus
###end article-title 137
###begin article-title 138
###xml 17 23 <span type="species:ncbi:10090">murine</span>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
A ligand for the murine NK activation receptor Ly-49D: activation of tolerized NK cells from beta 2-microglobulin-deficient mice
###end article-title 138
###begin article-title 139
###xml 14 20 <span type="species:ncbi:10090">murine</span>
###xml 126 132 <span type="species:ncbi:10090">murine</span>
Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D
###end article-title 139
###begin article-title 140
###xml 96 100 <span type="species:ncbi:10090">mice</span>
Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice
###end article-title 140
###begin article-title 141
NKG2D ligands: unconventional MHC class I-like molecules exploited by viruses and cancer
###end article-title 141
###begin article-title 142
###xml 16 22 <span type="species:ncbi:10090">murine</span>
Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages
###end article-title 142
###begin article-title 143
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
###end article-title 143
###begin article-title 144
Natural killer cells, viruses and cancer
###end article-title 144
###begin article-title 145
###xml 121 125 <span type="species:ncbi:10090">mice</span>
Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice
###end article-title 145
###begin article-title 146
###xml 112 116 <span type="species:ncbi:10090">mice</span>
Antimetastatic effect of NK1+ T cells on experimental haematogenous tumour metastases in the liver and lungs of mice
###end article-title 146
###begin article-title 147
Expression and function of asialo GM1 in alloreactive cytotoxic T lymphocytes
###end article-title 147
###begin article-title 148
###xml 24 35 <span type="species:ncbi:111938">gatekeepers</span>
Memory CD8+ T cells are gatekeepers of the lymph node draining the site of viral infection
###end article-title 148
###begin article-title 149
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
Mouse-pox; infectious ectromelia of mice; a review
###end article-title 149
###begin article-title 150
###xml 102 110 <span type="species:ncbi:10255">smallpox</span>
Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines
###end article-title 150
###begin article-title 151
Zoonotic orthopoxviruses encode a high-affinity antagonist of NKG2D
###end article-title 151
###begin article-title 152
###xml 15 29 <span type="species:ncbi:10245">vaccinia virus</span>
###xml 48 53 <span type="species:ncbi:9606">human</span>
Recognition of vaccinia virus-infected cells by human natural killer cells depends on natural cytotoxicity receptors
###end article-title 152
###begin article-title 153
Technical knockout: understanding poxvirus pathogenesis by selectively deleting viral immunomodulatory genes
###end article-title 153
###begin article-title 154
###xml 23 29 <span type="species:ncbi:10090">murine</span>
Physiological roles of murine DAP10 adapter protein in tumor immunity and autoimmunity
###end article-title 154
###begin article-title 155
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts
###end article-title 155
###begin article-title 156
###xml 16 20 <span type="species:ncbi:10090">mice</span>
DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming
###end article-title 156
###begin p 157
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. MF, LLL, and LJS designed research. MF performed research. LLL and LJS contributed reagents and analytic tools. MF, LLL, and LJS analyzed data. MF and LJS wrote the paper. MF, LLL, and LJS approved the final manuscript.
###end p 157
###begin p 158
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
Funding. This work was supported by National Institutes of Health Grants AI048849 and AI065544 (to LJS), AI066897 (to LLL), and CA006927 (to Fox Chase Cancer Center), and by an appropriation from the Commonwealth of Pennsylvania. LLL is an American Cancer Society Research Professor.
###end p 158
###begin p 159
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. LLL and the University of California (San Francisco, CA) have licensed intellectual property rights relating to NKG2D for commercial applications. The authors declare that no other competing interests exist.
###end p 159

